NeuroVasc
California, US · Founded 2015 · Delaware corporation · 22 employees on LinkedIn · 2 known investors
NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
Founders & leadership
JM
JIANLU MAExecutive
Board
LG
LU GANGBoard director
WD
JP
JEFF PETERSBoard director
DF
DAVE FERRERABoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$7.1M disclosed across 4 rounds · 2015–2018
▶$4.2MraisedMay 2018 · 9 investors · Other TechnologyRule 506(b)
▶$4.2MraisedMay 2018 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jianlu MaExecutive Officer, Director
- James HanDirector
- Michael LosordoExecutive Officer
- William DaiDirector
- Gang LuDirector
- Offering amount
- $6.4M
- Amount sold
- $4.2M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$500KraisedNov 2017 · 3 investors · Other Health CareRule 506(b)
▶$500KraisedNov 2017 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JIANLU MaExecutive Officer, Director
- Gang LuDirector
- William DaiDirector
- Offering amount
- $900K
- Amount sold
- $500K
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1MraisedDec 2016 · 3 investors · Other Health CareRule 506(b)
▶$1MraisedDec 2016 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gang LuDirector
- William DaiDirector
- Jeff PetersDirector
- JIANLU MaExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.4MraisedNov 2015 · 4 investors · Other Health CareRule 506(b)
▶$1.4MraisedNov 2015 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JEFF PETERSDirector
- LU GANGDirector
- DAVE FERRERADirector
- WILLIAM DAIDirector
- JIANLU MAExecutive Officer, Director
- Offering amount
- $2.7M
- Amount sold
- $1.4M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Rf Surgical27 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Innova Vascular26 shared keywordsInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Read the Press Release21 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Boston Scientific19 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Vantis Vascular17 shared keywordsVantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter>
<parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter>
<parameter name="hq_city">San Jose
Companies competing with NeuroVasc for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does NeuroVasc do?
- NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
- Who are NeuroVasc's investors?
- NeuroVasc's investors include ShangBay Capital LLC, Sv Tech Ventures, Inc..
- How much funding has NeuroVasc raised?
- NeuroVasc has disclosed $7.1M raised across 4 rounds.
- Where is NeuroVasc headquartered?
- NeuroVasc is headquartered in California, US.